{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:48:40Z","timestamp":1785804520969,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019432","name":"Fujiwara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tranon.2025.102324","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:07:21Z","timestamp":1740046041000},"page":"102324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma"],"prefix":"10.1016","volume":"54","author":[{"given":"Tetsuya","family":"Fukui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1676-1571","authenticated-orcid":false,"given":"Ryota","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi","family":"Menju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1450-0589","authenticated-orcid":false,"given":"Masashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102324_bib0001","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"Thieke","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0003","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma","volume":"18","author":"Carbone","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2025.102324_bib0004","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/ijerph15051000","article-title":"Global asbestos disaster","volume":"15","author":"Furuya","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.tranon.2025.102324_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12989-016-0162-4","article-title":"The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases","volume":"13","author":"Sayan","year":"2016","journal-title":"Part Fibre Toxicol."},{"key":"10.1016\/j.tranon.2025.102324_bib0006","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","article-title":"Inflammation-related IL1\u03b2\/IL1R signaling promotes the development of asbestos-induced malignant mesothelioma","volume":"9","author":"Kadariya","year":"2016","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.tranon.2025.102324_bib0007","first-page":"543","article-title":"Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophages","volume":"34","author":"Izzi","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0008","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-023-01816-9","article-title":"Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy","volume":"22","author":"Torricelli","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2025.102324_bib0009","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1111\/cas.14523","article-title":"Tumor-associated macrophage-derived inflammatory cytokine enhances malignant potential of malignant pleural mesothelioma","volume":"111","author":"Horio","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2025.102324_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350878","article-title":"Tumor-associated macrophages impair NK cell IFN-\u03b3 production and contribute to tumor progression in clear cell renal cell carcinoma","volume":"54","author":"N\u00fa\u00f1ez","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tranon.2025.102324_bib0011","article-title":"Defining and targeting tumor-associated macrophages in malignant mesothelioma","volume":"120","author":"Wu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tranon.2025.102324_bib0012","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","article-title":"Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time","volume":"29","author":"Pasello","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0013","first-page":"4490","article-title":"M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer","volume":"18","author":"Sumitomo","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.tranon.2025.102324_bib0014","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1111\/cas.15987","volume":"114","author":"Sumitomo","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2025.102324_bib0015","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ijo.2014.2761","article-title":"Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2\/STAT3\/snail pathway","volume":"46","author":"Fu","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0016","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11748-021-01595-4","article-title":"Lung cancer and epithelial-mesenchymal transition","volume":"69","author":"Menju","year":"2021","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.tranon.2025.102324_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein","volume":"10","author":"Chen","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tranon.2025.102324_bib0019","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/CJI.0000000000000517","article-title":"Comprehensive molecular analyses of an M2-like tumor-associated macrophage for predicting prognosis and immunotherapy in breast cancer","volume":"47","author":"Chang","year":"2024","journal-title":"J. Immunother."},{"key":"10.1016\/j.tranon.2025.102324_bib0020","doi-asserted-by":"crossref","first-page":"eaax6337","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tranon.2025.102324_bib0021","doi-asserted-by":"crossref","first-page":"E2801","DOI":"10.1073\/pnas.1707929115","article-title":"Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition","volume":"115","author":"Giurisato","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tranon.2025.102324_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","article-title":"Targeting tumor-associated macrophages for cancer treatment","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tranon.2025.102324_bib0023","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:21:56Z","timestamp":1744503716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":23,"alternative-id":["S1936523325000555"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102324","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102324"}}